sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology plc
The Vanguard Group, Inc. has released a Form 8.3 in compliance with the Irish Takeover Panel rules. This disclosure concerns The Vanguard Group's interests in Mural Oncology plc, specifically relating to relevant securities equating to 1% or more. The disclosure was made on October 8, 2025, with the position held on October 7, 2025.
As of the latest disclosure, The Vanguard Group, Inc. holds 288,827 ordinary shares of Mural Oncology plc, representing 1.67% of the relevant securities. In recent transactions, The Vanguard Group purchased 64 ordinary shares at $2.09 each and sold 16 shares at the same price.
No indemnity or gambling arrangements, or any similar agreements, have been entered into by The Vanguard Group in relation to Mural Oncology plc's securities. Similarly, there are no agreements concerning options or derivatives.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.